Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 7, 2019
The article highlights the significant impact of FDNA’s facial recognition technology in advancing genetic medicine. Using deep-learning technology to identify facial features associated with genetic disorders can greatly enhance clinical genetics evaluations and precision medicine. FDNA’s “DeepGestalt” technology exemplifies this approach, employing an advanced facial-analysis framework to highlight facial phenotypes linked to hundreds of diseases and genetic variations. This innovative tool supports more accurate and efficient diagnoses, contributing significant value to the field of clinical genetics and the broader pursuit of personalized medical care.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…